USPTO 2015–2025 USPTO PatentsView US Corporation

Amyris, Inc.

USPTO PatentsView assignee record - 74 granted patents across 38 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Amyris ranks #4,702 of 49,997 tracked US assignees by granted-patent volume, with 74 patents across 38 technology areas.

#4,702
of 49,997 US assignees by volume
Top 6%
by Innovation Score (56.3/100)
20.3
avg claims per patent
+13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4702 · US Corporation #4,702 · 74 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 74 grants
  • TOP-DECILE #4,702/49,997
  • PHOTO-FINISH 8ME Nova
  • CPC-FOCUS C12N · 38 areas
  • INNOV-PAR 56.3/100
  • CLAIMS-DENSE 20.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +13% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: 8ME Nova, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Amyris

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Amyris's Innovation Score is 56.3/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Amyris's grants concentrate

Amyris, Inc. is a focused PatentsView assignee: 38 CPC subclasses with 52.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (10 grants) versus a trough of 3 in 2019. By volume, Amyris sits between Think Surgical, Inc. and Alstom Renewable Technologies.

Amyris's three-year grant acceleration

Amyris, Inc. shows 20 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Amyris's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Amyris holds 74 patents at rank #4,699, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Amyris

By rank, the assignees closest to #4,699 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Amyris's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Amyris, neither rank-band nor same-CPC leaders (those blocks stay above).

Amyris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

24681012 20152016201720182019202020212022202320242025 8
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Amyris, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 5.4%
2016 5 6.8%
2017 10 13.5%
2018 9 12.2%
2019 3 4.1%
2020 8 10.8%
2021 7 9.5%
2022 7 9.5%
2023 4 5.4%
2024 9 12.2%
2025partial year 8 10.8%

Which technologies does Amyris, Inc. patent most?

Top 15 of 38 technology areas

Where it ranks

Overall rank by patents

#4,702

of 49,997 tracked assignees

Innovation Score

56.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Amyris, Inc.'s patent record in context - here's where to go next.

  • Amyris, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 52.7% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #4,702 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Amyris, Inc. against Think Surgical, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 56.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.